Cryomass Technologies Inc
Cryomass Technologies Inc., together with its subsidiaries, develops and licenses equipment to refine harvested cannabis, hemp, and other premium crops in the United States. It offers CryoSift Separator, which capture intact cannabis and hemp trichomes. The company was formerly known as Andina Gold Corp. and changed its name to Cryomass Technologies Inc. in August 2021. Cryomass Technologies Inc.… Read more
Market Cap & Net Worth: Cryomass Technologies Inc (CRYM)
Cryomass Technologies Inc (OTCQX:CRYM) has a market capitalization of $8.13 Million ($8.13 Million) as of March 19, 2026. Listed on the OTCQX stock exchange, this USA-based company holds position #42404 globally and #13716 in its home market, demonstrating a -1.15% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Cryomass Technologies Inc's stock price $0.03 by its total outstanding shares 237159877 (237.16 Million).
Cryomass Technologies Inc Market Cap History: 2015 to 2025
Cryomass Technologies Inc's market capitalization history from 2015 to 2025. Data shows change from $136.37 Million to $8.13 Million (-25.76% CAGR).
Cryomass Technologies Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Cryomass Technologies Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
745.50x
Cryomass Technologies Inc's market cap is 745.50 times its annual revenue
1.00x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $151.78 Million | $3.48 Million | -$3.06 Million | 43.63x | N/A |
| 2020 | $47.19 Million | $781.46K | -$11.82 Million | 60.39x | N/A |
| 2023 | $10.10 Million | $13.55K | -$12.96 Million | 745.50x | N/A |
Competitor Companies of CRYM by Market Capitalization
Companies near Cryomass Technologies Inc in the global market cap rankings as of March 19, 2026.
Key companies related to Cryomass Technologies Inc by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #422 globally with a market cap of $51.61 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #432 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #452 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #719 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #422 | Zoetis Inc | NYSE:ZTS | $51.61 Billion | $117.35 |
| #432 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.31 |
| #452 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #719 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Cryomass Technologies Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, Cryomass Technologies Inc's market cap moved from $136.37 Million to $ 8.13 Million, with a yearly change of -25.76%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $8.13 Million | +88.46% |
| 2024 | $4.32 Million | -57.28% |
| 2023 | $10.10 Million | -76.99% |
| 2022 | $43.90 Million | -31.44% |
| 2021 | $64.03 Million | +35.68% |
| 2020 | $47.19 Million | -68.91% |
| 2019 | $151.78 Million | +12700.00% |
| 2018 | $1.19 Million | 0.00% |
| 2017 | $1.19 Million | 0.00% |
| 2016 | $1.19 Million | -99.13% |
| 2015 | $136.37 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of Cryomass Technologies Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $8.13 Million USD |
| MoneyControl | $8.13 Million USD |
| MarketWatch | $8.13 Million USD |
| marketcap.company | $8.13 Million USD |
| Reuters | $8.13 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.